These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Suppression of VLDL associated triacylglycerol secretion by both alpha- and beta-adrenoceptor agonists in isolated rat hepatocytes. Rasouli M; Zahraie M Eur J Pharmacol; 2006 Sep; 545(2-3):109-14. PubMed ID: 16876783 [TBL] [Abstract][Full Text] [Related]
7. The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344. Oriowo MA; Chapman H; Kirkham DM; Sennitt MV; Ruffolo RR; Cawthorne MA J Pharmacol Exp Ther; 1996 Apr; 277(1):22-7. PubMed ID: 8613923 [TBL] [Abstract][Full Text] [Related]
8. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067 [TBL] [Abstract][Full Text] [Related]
9. Beta-adrenoceptor responses of the airways: for better or worse? Broadley KJ Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310 [TBL] [Abstract][Full Text] [Related]
10. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628 [TBL] [Abstract][Full Text] [Related]
11. Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket". Zhang X; De Los Angeles JE; He MY; Dalton JT; Shams G; Lei L; Patil PN; Feller DR; Miller DD; Hsu FL J Med Chem; 1997 Sep; 40(19):3014-24. PubMed ID: 9301663 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach. Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Box PC; Butchers PR; Coe DM; Conroy R; Emmons A; Ford AJ; Holmes DS; Horsley H; Kerr F; Li-Kwai-Cheung AM; Looker BE; Mann IS; McLay IM; Morrison VS; Mutch PJ; Smith CE; Tomlin P J Med Chem; 2010 Jun; 53(11):4522-30. PubMed ID: 20462258 [TBL] [Abstract][Full Text] [Related]
13. Further characterization of beta3-adrenoceptors in the guinea pig gastric fundus: stereoselectivity, beta-adrenoceptor alkylation, and structure-activity relationship. Horinouchi T; Koike K Can J Physiol Pharmacol; 2001 Dec; 79(12):985-95. PubMed ID: 11824942 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of inverse agonists for G-protein-coupled receptors. Soudijn W; van Wijngaarden I; Ijzerman AP Med Res Rev; 2005 Jul; 25(4):398-426. PubMed ID: 15816047 [TBL] [Abstract][Full Text] [Related]
15. Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations. Washburn WN; Harper TW; Wu G; Godfrey JD; McCann P; Girotra R; Shao C; Zhang H; Gavai A; Mikkilineni A; Dejneka T; Ahmed S; Caringal Y; Hangeland J; Zhang M; Cheng PT; Russell AD; Skwish S; Slusarchyk DA; Allen GT; Frohlich BH; Abboa-Offei BE; Cap M; Waldron TL; George RJ; Tesfamariam B; Dickinson KE; Seymour AA; Sher PM Bioorg Med Chem Lett; 2007 Aug; 17(15):4290-6. PubMed ID: 17533126 [TBL] [Abstract][Full Text] [Related]
16. Identification of potent agonists acting at an endogenous atypical beta3-adrenoceptor state that modulate lipolysis in rodent fat cells. Hamilton BS; Doods HN Eur J Pharmacol; 2008 Feb; 580(1-2):55-62. PubMed ID: 18031735 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig. Haynes JM; Hill SJ Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1,2-benzisothiazolyloxypropanolamine derivatives and investigation of their activity at beta-adrenoceptors. Morini G; Pozzoli C; Menozzi A; Comini M; Poli E Farmaco; 2005 Oct; 60(10):810-7. PubMed ID: 16154571 [TBL] [Abstract][Full Text] [Related]
19. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists. Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239 [TBL] [Abstract][Full Text] [Related]
20. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]